A major motivation for this study was our recent findings that CDG caused by deficiencies in the GALNT2 (33) and GALNT11 (manuscript in prep) genes involves neurodevelopmental and intellectual impairments. The gene discussed is GALNT2; the disease is congenital disorder of glycosylation.